| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/20/1992 | WO1992013874A2 Angiogenic peptides |
| 08/20/1992 | WO1992013870A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | WO1992013867A1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 08/20/1992 | WO1992013553A2 Method and agents for promoting wound healing |
| 08/20/1992 | WO1992013550A1 Recombinant transferrins, transferrin half-molecules and mutants thereof |
| 08/20/1992 | WO1992007940A3 Bovine respiratory syncytial virus genes |
| 08/20/1992 | WO1992006113A3 Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant |
| 08/20/1992 | WO1992001782A3 Sucrose phosphate synthetase (sps), a preparation method and cdna therefor, and use of the cdna for modifying sps expression in plant cells |
| 08/20/1992 | DE4204476A1 Cyclodextrinase gene from bacillus Sphaericus E-244 - used in the prodn. of cyclodextrinase in E coli |
| 08/20/1992 | DE4104782A1 Neue plasmide, enthaltend dna-sequenzen, die veraenderungen der karbohydratkonzentration und karbohydratzusammensetzung in pflanzen hervorrufen, sowie pflanzen und pflanzenzellen enthaltend dieses plasmide New plasmids containing dna sequences that cause the end of the karbohydratkonzentration ments and karbohydratzusammensetzung cause in plants, and plants and plant cells containing plasmids of this |
| 08/20/1992 | CA2638662A1 Specific peptidic sequences of p. falciparum heptatic stages that carry epitopes capable of stimulating t lymphocytes |
| 08/20/1992 | CA2103893A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | CA2103676A1 Method and agents for promoting wound healing |
| 08/20/1992 | CA2103550A1 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
| 08/20/1992 | CA2101632A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | CA2100775A1 .beta.-1,4-galactanase and a dna sequence |
| 08/20/1992 | CA2079871A1 Vaccine |
| 08/20/1992 | CA2079870A1 Vaccine |
| 08/19/1992 | EP0499555A1 Recombinant DNA coding for a T-cell receptor chain, process for preparation and antibodies and pharmaceutical compositions comprising the same |
| 08/19/1992 | EP0499292A1 Genetic system for micromonospora |
| 08/19/1992 | EP0499176A2 Monoclonal antibodies against human pancreatic islet cells |
| 08/19/1992 | EP0499161A2 GM-CSF inhibiting antibodies |
| 08/19/1992 | EP0499112A1 Antibodies against an IgE receptor |
| 08/19/1992 | EP0499059A1 Suppressor-tRNA-genetranscription system |
| 08/19/1992 | EP0499010A1 A method for measuring the activity of angiotensin converting enzyme in biological samples |
| 08/19/1992 | EP0499003A1 Polypeptides and peptides, particularly recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis |
| 08/19/1992 | EP0498905A1 Conformational epitopes of human immunodeficiency virus envelope glycoprotein gp120 |
| 08/19/1992 | EP0498843A1 Oligonucleotide analogs with novel linkages. |
| 08/19/1992 | EP0498838A1 Method for synthesizing adenosine phosphate derivatives and derivatives thereby obtained |
| 08/19/1992 | EP0498827A1 Improved plasmid vectors for cellular slime moulds of the genus dictyostelium |
| 08/19/1992 | EP0472638A4 Method for isolating receptors having a preselected specificity |
| 08/19/1992 | EP0449956A4 Novel lymphokine/cytokine genes |
| 08/19/1992 | EP0425661A4 A new method for tapping the immunological repertoire |
| 08/19/1992 | EP0314744B1 Monokine dosing |
| 08/19/1992 | EP0153961B1 Recombinant materials and methods for producing human connective tissue-activating peptide-iii and analogs thereof |
| 08/19/1992 | CN1017906B Process for producing l-lysine |
| 08/18/1992 | US5140103 Quanitative analysis of telopeptides crosslinked by hydroxylysyl pyridinoline(HP) or lysyl pyridinoline(LP) derived from bone collagen reabsorption |
| 08/18/1992 | US5139954 External control of selected genes in plant cells by use of nucleic acid promoter fragments |
| 08/18/1992 | US5139950 PTR2030, a conjugal plasmid and derivatives thereof that confer phage resistance to group N streptococci |
| 08/18/1992 | US5139942 Method for producing the nde i restriction endonuclease and methylase |
| 08/18/1992 | US5139941 AAV transduction vectors |
| 08/18/1992 | US5139940 Activation compounds and methods of synthesis of activation compounds |
| 08/18/1992 | US5139937 Process for producing apoaequorin |
| 08/18/1992 | US5139936 Use of the GAL1 yeast promoter |
| 08/18/1992 | US5139935 Method of regulating expression of a foreign gene by controlling the sugar concentration in a medium and a process of producing a foreign product thereby |
| 08/18/1992 | CA1306433C Microorganisms and processes for degrading plant cell walls and halogenated hydrocarbons |
| 08/18/1992 | CA1306431C Nucleic acid probes for prenatal sexing |
| 08/18/1992 | CA1306430C Monoclonal antibody |
| 08/18/1992 | CA1306428C Monoclonal antibody specific for a mammary tumor cell surface antigen |
| 08/16/1992 | WO1992014488A1 Structural gene of pneumococcal protein |
| 08/16/1992 | CA2061266A1 Recombinant dna molecules coding for a sequence of the t-cell antigen receptor, process for its preparation, and antibodies and medicament containing them |
| 08/15/1992 | WO1992014755A1 A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN |
| 08/15/1992 | CA2101919A1 Integrin specificity for the hiv tat protein |
| 08/13/1992 | DE4104240A1 Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren Receptors cloning of a new member of the family of fibroblast growth factors (FGF) |
| 08/12/1992 | EP0498767A2 Chimeric antiidiotypic monoclonal antibodies |
| 08/12/1992 | EP0498537A2 Novel coleopteran-active bacillus thuringiensis isolate and a novel gene encoding a coleopteran-active toxin |
| 08/12/1992 | EP0498404A1 A type II restriction endonuclease obtainable from arthrobacter species and a process for producing the same |
| 08/12/1992 | EP0498137A1 Novel expression systems |
| 08/12/1992 | EP0498124A1 Monoclonal antibodies to mite allergen and the use thereof |
| 08/12/1992 | EP0497950A1 Mutation of hrv2 2a |
| 08/12/1992 | EP0497922A1 Infective protein delivery system |
| 08/12/1992 | EP0497921A1 Activation compounds and methods for nucleic acid sterilization |
| 08/12/1992 | EP0497916A1 Expression of bacterial hemoglobin and enhancement of expression of cloned and native products in streptomyces |
| 08/12/1992 | EP0497911A1 Recombinant production of lactoperoxidase |
| 08/12/1992 | EP0497904A1 Compositions containing plant-produced glycopolypeptide multimers and methods for their production |
| 08/12/1992 | EP0497897A1 Diagnosis of glomerulonephritis |
| 08/12/1992 | EP0497894A1 Receptor infection assay |
| 08/12/1992 | EP0497892A1 Dna molecules improving cold-resistance |
| 08/12/1992 | EP0497885A1 Array-type multiple cell injector |
| 08/12/1992 | EP0497884A1 Glutamate receptor compositions and methods |
| 08/12/1992 | EP0497883A1 Compositions and their use for promoting immunopotentiation |
| 08/12/1992 | EP0497878A1 Method for producing secretable glycosyltransferases |
| 08/12/1992 | EP0497875A1 2' modified oligonucleotides |
| 08/12/1992 | EP0497866A1 Gastrin releasing peptide receptor |
| 08/12/1992 | EP0497833A1 C1 inhibitor muteins and uses thereof |
| 08/12/1992 | EP0497784A1 Quantitation of nucleic acids using the polymerase chain reaction |
| 08/12/1992 | EP0494955A4 Cell-free synthesis and isolation of novel genes and polypeptides |
| 08/12/1992 | EP0489780A4 Fusion proteins, their preparation and use |
| 08/12/1992 | EP0489062A4 Bone-specific protein |
| 08/12/1992 | EP0463081A4 Hormone response element compositions and assay |
| 08/12/1992 | EP0456766A4 Type oc platelet-derived growth factor receptor gene |
| 08/12/1992 | EP0188450B1 Methods for the in vitro detection and identification of unknown pathogens or genetic entities |
| 08/12/1992 | EP0160699B1 Production of heterodimeric human fertlity hormones |
| 08/12/1992 | CN1063507A Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 08/12/1992 | CN1063506A Recombinant promoter for gene expression in monocotyledonous plants |
| 08/12/1992 | CN1063416A Avirulent microbes and uses therefor:salmonella typhi |
| 08/12/1992 | CA2060741A1 Gm-csf inhibiting oligopeptides |
| 08/12/1992 | CA2059842A1 Ige-receptor-antibodies |
| 08/11/1992 | US5138045 Polyamine conjugated oligonucleotides |
| 08/11/1992 | US5137877 Bifunctional linking compounds, conjugates and methods for their production |
| 08/11/1992 | US5137829 DNA transposon TN5SEQ1 |
| 08/11/1992 | US5137824 Csf-1 gene promoter |
| 08/11/1992 | US5137823 Method for producing the bamhi restriction endonuclease and methylase |
| 08/11/1992 | US5137822 Yeast expression plasmid consist of yeast alcohol dehydrogenase and bovine adrenocortical cytochrome P-450-17-alpha cDNA |
| 08/11/1992 | US5137821 Gene and process of making glucose-6-phosphate dehydrogenase |
| 08/11/1992 | US5137819 Cellulose binding fusion proteins for immobilization and purification of polypeptides |
| 08/11/1992 | US5137817 Apparatus and method for electroporation |
| 08/11/1992 | US5137816 Controlled gene expression |
| 08/11/1992 | US5137814 Altering nucleic acid sequence at the termini of target sequence |
| 08/11/1992 | US5137721 Vaccine for preventionof gastointestinal disorder |